LYON, France, Nov. 2, 2016 /PRNewswire/ -- Mapi Research Trust expands their North American presence to support increased demand for information on Clinical Outcome Assessments (COAs). The expanding application and use of Clinical Outcome Assessments (COAs) both in Clinical Research and Clinical Care has increased the level of support that the Mapi Research Trust provides to researchers and health care providers. To support the life science industry, physicians and Health Care Organizations, the Mapi Research Trust is expanding our staff in North America.
"The expansion of United States staff in our growing Boston, MA, location strengthens Mapi Research Trust's mission of giving a voice to the patient across the spectrum of health care from clinical research to therapeutic care globally," Commented Katrin Conway, Managing Director of the Mapi Research Trust. Mapi founded the Not-for-Profit Mapi Research Trust in 2004 to support the adoption of Patient Outcomes in health research; since then, Mapi Research Trust has been dedicated to improving the uptake and application of patient outcomes and Quality Of Life measures by promoting collaborative initiatives among researchers, pharmaceutical companies and international organizations with the objective of incorporating the patient's voice into the development process of new treatments. "From the start we believed that patients must be the heart of Health Research and Healthcare. That the lives of patients can be improved through the application of Clinical Outcomes Assessments (COAs) both in Health Research and Clinical Care," Commented Bernard Jambon, Mapi Research Trust Chairman, "The addition of Outcome Measures into Clinical Care as measures of patient value is a natural evolution for health systems that seek to improve patients' health and quality of life."